Nanoscale Research Letters · 2012 · 192 citations · 25 references
PharmacyBiochemistryToxicologyBiochemical ToxicologyHepatotoxicologyRedox BiochemistryHepatotoxicity MechanismsMitochondrial ToxicityMitochondrial ToxicologyNanotoxicologyZinc ToxicityZinc ToxicologyCell Death AssaysHepatocyte MorphologyLipid Peroxidation MarkersNanoparticlesOxidative Dna DamageOxidative MarkersOxidative Stress InjuryZinc-induced Genotoxicity
Traces of zinc oxide nanoparticles (ZnO NPs) used may be found in the liver and kidney. The aim of this study is to determine the optimal viability assay for using with ZnO NPs and to assess their toxicity to human hepatocyte (L02) and human embryonic kidney (HEK293) cells. Cellular morphology, mitochondrial function (MTT assay), and oxidative stress markers (malondialdehyde, glutathione (GSH) and superoxide dismutase (SOD)) were assessed under control and exposed to ZnO NPs conditions for 24 h. The results demonstrated that ZnO NPs lead to cellular morphological modifications, mitochondrial dysfunction, and cause reduction of SOD, depletion of GSH, and oxidative DNA damage. The exact mechanism behind ZnO NPs toxicity suggested that oxidative stress and lipid peroxidation played an important role in ZnO NPs-elicited cell membrane disruption, DNA damage, and subsequent cell death. Our preliminary data suggested that oxidative stress might contribute to ZnO NPs cytotoxicity.
25
Günter Oberdörster, Andrew Maynard, Ken Donaldson et al. · Particle and Fibre Toxicology · 2005 · 2.1K citations · Full text
Hui Yang, Chao Liu, Danfeng Yang et al. · Journal of Applied Toxicology · 2008 · 1.1K citations
DNA damaging potential of zinc oxide nanoparticles in human epidermal cells
Vyom Sharma, Ritesh K. Shukla, Neha Saxena et al. · Toxicology Letters · 2009 · 629 citations